These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 38963127)

  • 21. Self-report instruments of cognitive failures as screening tools for Subjective Cognitive Impairment in older adults.
    Papaliagkas V; Papantoniou G; Tsolaki M; Moraitou D
    Hell J Nucl Med; 2017; 20 Suppl():58-70. PubMed ID: 29324915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood biomarkers as surrogate endpoints of treatment responses to aerobic exercise and cognitive training (ACT) in amnestic mild cognitive impairment: the blood biomarkers study protocol of a randomized controlled trial (the ACT Trial).
    Li D; Mielke MM; Bell WR; Reilly C; Zhang L; Lin FV; Yu F
    Trials; 2020 Jan; 21(1):19. PubMed ID: 31907024
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Translation and psychometric evaluation of a Persian version of the functional assessment staging scale (I-FAST) in older patients with mild cognitive impairment and Alzheimer's disease in Iran.
    Noroozian M; Reisberg B; Farhadi A; Sharifi F; Sadeghi Zangeneh A; Mohammadi M
    Acta Neurol Belg; 2022 Aug; 122(4):987-996. PubMed ID: 34152582
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Novel Computerized Cognitive Stress Test to Detect Mild Cognitive Impairment.
    Curiel Cid RE; Crocco EA; Kitaigorodsky M; Beaufils L; Peña PA; Grau G; Visser U; Loewenstein DA
    J Prev Alzheimers Dis; 2021; 8(2):135-141. PubMed ID: 33569559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Three-month stability of the CogState brief battery in healthy older adults, mild cognitive impairment, and Alzheimer's disease: results from the Australian Imaging, Biomarkers, and Lifestyle-rate of change substudy (AIBL-ROCS).
    Lim YY; Jaeger J; Harrington K; Ashwood T; Ellis KA; Stöffler A; Szoeke C; Lachovitzki R; Martins RN; Villemagne VL; Bush A; Masters CL; Rowe CC; Ames D; Darby D; Maruff P
    Arch Clin Neuropsychol; 2013 Jun; 28(4):320-30. PubMed ID: 23552802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic and Prognostic Value of the Combination of Two Measures of Verbal Memory in Mild Cognitive Impairment due to Alzheimer's Disease.
    Sala I; Illán-Gala I; Alcolea D; Sánchez-Saudinós MB; Salgado SA; Morenas-Rodríguez E; Subirana A; Videla L; Clarimón J; Carmona-Iragui M; Ribosa-Nogué R; Blesa R; Fortea J; Lleó A
    J Alzheimers Dis; 2017; 58(3):909-918. PubMed ID: 28527215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A neuropsychological test battery for use in Alzheimer disease clinical trials.
    Harrison J; Minassian SL; Jenkins L; Black RS; Koller M; Grundman M
    Arch Neurol; 2007 Sep; 64(9):1323-9. PubMed ID: 17846273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of an UPSA Short Form for Use in Longitudinal Studies in the Early Alzheimer's Disease Spectrum.
    Goldberg TE; Harvey PD; Devanand DP; Keefe RSE; Gomar JJ
    J Prev Alzheimers Dis; 2020; 7(3):179-183. PubMed ID: 32463071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 18F-Flortaucipir PET Associations with Cerebrospinal Fluid, Cognition, and Neuroimaging in Mild Cognitive Impairment due to Alzheimer's Disease.
    Okafor M; Nye JA; Shokouhi M; Shaw LM; Goldstein F; Hajjar I
    J Alzheimers Dis; 2020; 74(2):589-601. PubMed ID: 32065800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of glial and neuronal degeneration markers with Alzheimer's disease cerebrospinal fluid profile and cognitive functions.
    Teitsdottir UD; Jonsdottir MK; Lund SH; Darreh-Shori T; Snaedal J; Petersen PH
    Alzheimers Res Ther; 2020 Aug; 12(1):92. PubMed ID: 32753068
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methodological improvements in quantifying cognitive change in clinical trials: an example with single-dose administration of donepezil.
    Pietrzak RH; Maruff P; Snyder PJ
    J Nutr Health Aging; 2009 Mar; 13(3):268-73. PubMed ID: 19262966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Do Alzheimer's and Lewy body disease have discrete pathological signatures of gait?
    Mc Ardle R; Galna B; Donaghy P; Thomas A; Rochester L
    Alzheimers Dement; 2019 Oct; 15(10):1367-1377. PubMed ID: 31548122
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discriminative capacity and construct validity of the Clock Drawing Test in Mild Cognitive Impairment and Alzheimer's disease.
    Duro D; Freitas S; Tábuas-Pereira M; Santiago B; Botelho MA; Santana I
    Clin Neuropsychol; 2019 Oct; 33(7):1159-1174. PubMed ID: 30422076
    [No Abstract]   [Full Text] [Related]  

  • 34. The Apathy Evaluation Scale (AES-C): Psychometric Properties and Invariance of Italian Version in Mild Cognitive Impairment and Alzheimer's Disease.
    Furneri G; Platania S; Privitera A; Martelli F; Smeriglio R; Razza G; Maci T; Castellano S; Drago F; Santagati M; Caponnetto P; Caraci F; Di Nuovo S
    Int J Environ Res Public Health; 2021 Sep; 18(18):. PubMed ID: 34574524
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative.
    Veitch DP; Weiner MW; Aisen PS; Beckett LA; Cairns NJ; Green RC; Harvey D; Jack CR; Jagust W; Morris JC; Petersen RC; Saykin AJ; Shaw LM; Toga AW; Trojanowski JQ;
    Alzheimers Dement; 2019 Jan; 15(1):106-152. PubMed ID: 30321505
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of a Cognitive Composite for Preclinical Alzheimer's Disease in Korean Older Adults.
    Kim M; Yi D; Byun MS; Ahn H; Jung JH; Kong N; Chang Y; Choi H; Choi J; Kim K; Jung G; Lee DY;
    J Alzheimers Dis; 2023; 96(2):633-641. PubMed ID: 37807780
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mini Mental State Examination and Logical Memory scores for entry into Alzheimer's disease trials.
    Chapman KR; Bing-Canar H; Alosco ML; Steinberg EG; Martin B; Chaisson C; Kowall N; Tripodis Y; Stern RA
    Alzheimers Res Ther; 2016 Feb; 8():9. PubMed ID: 26899835
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional Network Alterations Associated with Cognition in Pre-Clinical Alzheimer's Disease.
    Fountain-Zaragoza S; Liu H; Benitez A
    Brain Connect; 2023 Jun; 13(5):275-286. PubMed ID: 36606679
    [No Abstract]   [Full Text] [Related]  

  • 39. Partial Least Squares Regression Analysis of Alzheimer's Disease Biomarkers, Modifiable Health Variables, and Cognitive Change in Older Adults with Mild Cognitive Impairment.
    Stark J; Hiersche KJ; Yu JC; Hasselbach AN; Abdi H; Hayes SM;
    J Alzheimers Dis; 2023; 93(2):633-651. PubMed ID: 37066909
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Contribution of Cerebral Vascular Neuropathology to Mild Stage of Alzheimer's Dementia Using the NACC Database.
    Liu Y; Chan DK; Crawford JD; Sachdev PS; Braidy N
    Curr Alzheimer Res; 2020; 17(13):1167-1176. PubMed ID: 33583381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.